1. Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease. (16th September 2021) Authors: Sandborn, William J; Lewis, James D; Panes, Julian; Loftus, Edward V; D'Haens, Geert; Yu, Zhuqing; Huang, Bidan; Lacerda, Ana P; Pangan, Aileen L; Feagan, Brian G Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 3(2022) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study. Issue 11 (November 2017) Authors: Westera, Liset; van Viegen, Tanja; Jeyarajah, Jenny; Azad, Azar; Bilsborough, Janine; van den Brink, Gijs R; Cremer, Jonathan; Danese, Silvio; D'Haens, Geert; Eckmann, Lars; Faubion, William; Filice, Melissa; Korf, Hannelie; McGovern, Dermot; Panes, Julian; Salas, Azucena; Sandborn, William J; Si... Journal: Clinical and translational gastroenterology Issue: Volume 8:Issue 11(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum: Evolving Concepts in Phases I and II Drug Development for Crohn's Disease. (16th March 2018) Authors: Jairath, Vipul; Levesque, Barrett G; Vande Casteele, Niels; Khanna, Reena; Mosli, Mahmoud; Hindryckx, Pieter; Travis, Simon; Duijvestein, Marjolijn; Rimola, Jordi; Panes, Julian; D'Haens, Geert; Sandborn, William J; Feagan, Brian G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 5(2018:May) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of an index to define overall disease severity in IBD. Issue 2 (25th October 2016) Authors: Siegel, Corey A; Whitman, Cynthia B; Spiegel, Brennan M R; Feagan, Brian; Sands, Bruce; Loftus, Edward V; Panaccione, Remo; D'Haens, Geert; Bernstein, Charles N; Gearry, Richard; Ng, Siew C; Mantzaris, Gerassimos J; Sartor, Balfour; Silverberg, Mark S; Riddell, Robert; Koutroubakis, Ioannis E; O'... Journal: Gut Issue: Volume 67:Issue 2(2018) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme. (11th March 2020) Authors: Sandborn, William J; Nguyen, Deanna D; Beattie, David T; Brassil, Patrick; Krey, Whitney; Woo, Jacky; Situ, Eva; Sana, Reuben; Sandvik, Erik; Pulido-Rios, M Teresa; Bhandari, Raj; Leighton, Jonathan A; Ganeshappa, Ravi; Boyle, David L; Abhyankar, Brihad; Kleinschek, Melanie A; Graham, Richard A; ... Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 9(2020) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Issue 5 (20th October 2022) Authors: Peyrin‐Biroulet, Laurent; Ghosh, Subrata; Lee, Scott D.; Lee, Wan‐Ju; Griffith, Jenny; Wallace, Kori; Berg, Sofie; Liao, Xiaomei; Panes, Julian; Loftus, Edward V.; Louis, Edouard Journal: Alimentary pharmacology & therapeutics Issue: Volume 57:Issue 5(2023) Page Start: 496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies. Issue 10383 (8th April 2023) Authors: Sandborn, William J; Vermeire, Séverine; Peyrin-Biroulet, Laurent; Dubinsky, Marla C; Panes, Julian; Yarur, Andres; Ritter, Timothy; Baert, Filip; Schreiber, Stefan; Sloan, Sheldon; Cataldi, Fabio; Shan, Kevin; Rabbat, Christopher J; Chiorean, Michael; Wolf, Douglas C; Sands, Bruce E; D'Haens, Ge... Journal: Lancet Issue: Volume 401:Issue 10383(2023) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OTU-003 Etrolizumab as induction therapy in moderate to severe crohn's disease: results from bergamot cohort 1. (8th June 2018) Authors: Selinger, Christian; Sandborn, William; Panes, Julian; Jones, Jennifer; Hassanali, Azra; Jacob, Rhian; Sharafali, Zaineb; Oh, Young; Tole, Swati Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-180 Etrasimod (APD334), a Potent, Selective, Oral S1P Receptor Modulator with Autoimmune Disease-Modifying Activity Exhibiting Favorable PK/PD Properties in Healthy Volunteers. (February 2017) Authors: Schreiber, Stefan; Morgan, Michael; Christopher, Ronald; Raether, Brian; Lassen, Cheryl; Sanchez-Kam, Matilde; Shanahan, William; Panes, Julian Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P035 ETROLIZUMAB TREATMENT MODULATES SOLUBLE MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN'S DISEASE. (7th February 2019) Authors: Sandborn, William J; Panes, Julian; Fuh, Franklin; Erickson, Rich; Jacob, Rhian; Zhang, Wenhui; Tang, Meina T; McBride, Jacqueline Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗